- AttorneyOne.com – Finding An Attorney Online, Just Got Easier

The US FDA notified HIV/AIDS, Infectious Disease healthcare professionals about a serious complication in the liver, non-cirrhotic portal hypertension, in patients using Videx or Videx EC (didanosine). Background of Videx/Videx EC (didanosine) Videx/Videx EC (didanosine) is used to treat human immunodeficiency virus (HIV) infection. FDA Alert on Videx/Videx EC (didanosine) Cases of non-cirrhotic portal hypertension [...]

[update] Healthcare professionals are notified by the FDA that co-administration of Victrelis (boceprevir) with certain ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitors is not recommended.  The Victrelis drug label has been revised accordingly. Background of Victrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs Victrelis (boceprevir) is a hepatitis C virus (HCV) protease [...]

A safety alert on the combination of Statins, Hepatitis C and HIV drugs has been brought to the attention of medical practitioners in infectious diseases, family practice, as well as patients at large. Medical professionals are hereby being updated of the changes in prescription details when administering combinations of protease inhibitors for either HCV or [...]

Pharmacists, doctors and consumers have been notified of the identified drug interactions between the protease inhibiting drug for Hepatits C Virus (HCV), Boceprevir (Victrelis), and the protease inhibiting drug for Human Immunodeficiency Virus (HIV), Ritonavir (Norvir). Persons already under medication for chronic Hepatitis C with Boceprevir (Victrelis), and at the same time doing an antiretroviral [...]